Carla M.L. van Herpen
Radboud University Nijmegen(NL)Radboud University Medical Center(NL)Radboud Institute for Molecular Life Sciences(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Lung Cancer Treatments and Mutations, Head and Neck Cancer Studies, Salivary Gland Tumors Diagnosis and Treatment
Most-Cited Works
- → Pan-cancer whole-genome analyses of metastatic solid tumours(2019)1,156 cited
- → MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study(2013)639 cited
- → Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study(2019)550 cited
- → Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck(2009)380 cited
- → Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice(2011)343 cited
- → The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs(2019)262 cited